{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T11:12:09Z","timestamp":1694776329224},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>There is an association between the presence of neuroendocrine neoplasms and incremented risk to develop second primary malignancies. This risk is estimated to be 17%. The most common secondary neoplasms were found in the Gastrointestinal and Genitourinary tracts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 74-year-old Caucasian patient with melaena came to our observation in June 2015. The Esophago-gastro-duodenoscopy exam found a polypoid formation in the duodenal bulb. Histopathological examination showed a well-differentiated neuroendocrine neoplasm (G1).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>During the follow up for the neuroendocrine neoplasm, a CT scan was performed in August 2016 describing infiltration of the right renal sinus and the third proximal ureter segment with heterogeneous enhancement of vascular structure. An US-guided biopsy was conclusive for a Diffuse Large B Cell Lymphoma. In October 2016, a colonoscopy showed a neoplastic lesion at 20\u200acm from the anal orifice. The Histology exam was positive for an adenocarcinoma with a desmoplastic stroma infiltration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>In November 2016, the patient underwent a left hemicolectomy: the pathologic staging described a G2 adenocarcinoma pT3N1b. In May 2018, the Octreotide scan was negative. In the same month, the patient started a treatment based on 6 cycles of Rituximab, Oxaliplatin, and Capecitabine due to the persistence of lymphomatous disease and hepatic metastases. In July 2018, other 3 cycles of the same treatment were scheduled.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>In January 2019, due to an increase in liver metastases\u2019 size, it was decided to start a new regimen for the colon cancer with FOLFIRI+Cetuximab. The patient is still in treatment with this regimen in April 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The risk of a second primary tumor is increased among patients older than 70. Therefore, it is necessary to follow them using total body CT scan and endoscopic techniques of gastrointestinal and genitourinary tracts, not only for the evaluation of the neuroendocrine tumor but also for the higher risk to develop other neoplastic diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016508","type":"journal-article","created":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T21:21:17Z","timestamp":1563744077000},"page":"e16508","source":"Crossref","is-referenced-by-count":0,"title":["Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract"],"prefix":"10.1097","volume":"98","author":[{"given":"Angelo","family":"Pirozzi","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Riccardi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Azienda Ospedaliero-Universitaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Arpino","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Mocerino","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Azienda Ospedaliero-Universitaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severo","family":"Campione","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Molino","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero-Universitaria, Naples, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Carten\u00ec","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Azienda Ospedaliero-Universitaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1158\/1078-0432.CCR-08-0734","article-title":"Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution","volume":"14","author":"Ekeblad","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/erc.1.01017","article-title":"Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization","volume":"12","author":"Panzuto","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/annonc\/mdm552","article-title":"Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours","volume":"19","author":"Bettini","year":"2008","journal-title":"Ann Oncol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11605-009-1115-0","article-title":"Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients","volume":"14","author":"Franko","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2010.33.0688","article-title":"Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression","volume":"129","author":"Panzuto","year":"2011","journal-title":"J Clin Oncol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000334038","article-title":"Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors","volume":"96","author":"Panzuto","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ejca.2011.10.030","article-title":"Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections","volume":"48","author":"Boninsegna","year":"2012","journal-title":"Eur J Cancer"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/1096-9098(200012)75:4<306::AID-JSO14>3.0.CO;2-3","article-title":"Gastrointestinal carcinoid tumors and second primary malignancies","volume":"75","author":"Habal","year":"2000","journal-title":"J Surg Oncol"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1371\/journal.pone.0086414","article-title":"Second cancers in patients with neuroendocrine tumors","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.1473","article-title":"Familial carcinoid tumors and subsequent cancer: a nation-wide epidemiologic study from Sweden","volume":"94","author":"Hemminki","year":"2001","journal-title":"Int J Cancer"},{"key":"R14-20230914","first-page":"1049","article-title":"Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact","volume":"24","author":"Prommegger","year":"2004","journal-title":"Anticancer res"},{"key":"R15-20230914","first-page":"182","article-title":"Malignant diathesis from jejunal-ileal carcinoids","volume":"84","author":"Zucker","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.1994.tb17255.x","article-title":"Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors and prognostic factors for, survival","volume":"733","author":"Oberg","year":"1994","journal-title":"Ann, NY, Acad, Sci"},{"key":"R17-20230914","first-page":"1377","article-title":"Cholecystokinin (CCK)-A and (CCK)-B\/gastrin receptors in human tumors","volume":"57","author":"Reubi","year":"1997","journal-title":"Cancer Res"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1210\/jcem.84.1.5400","article-title":"High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents","volume":"84","author":"Schaer","year":"1999","journal-title":"J Clin Endocrinol Metabol"},{"issue":"(6A)","key":"R19-20230914","first-page":"4051","article-title":"Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptor status","volume":"18","author":"Bold","year":"1998","journal-title":"Anticancer Res"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/316823a0","article-title":"Bombesin like peptides can function as autocrine growth factors in human small cell lung cancers","volume":"316","author":"Cuttita","year":"1985","journal-title":"Nature"},{"key":"R21-20230914","first-page":"2085","article-title":"Expression of transforming growth factors beta1,beta2,beta 3 in neuroendocrine tumors of the digestive system","volume":"14","author":"Chaudhry","year":"1994","journal-title":"Anticancer Res"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1530\/ERC-11-0315","article-title":"Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas","volume":"19","author":"Kamp","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1245\/s10434-014-3774-7","article-title":"Incidence of additional primary malignancies in patients with pancreatic of gastrointestinal neuroendocrine tumors","volume":"21","author":"Kauffmann","year":"2014","journal-title":"Ann Surg Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201907190-00059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:40:12Z","timestamp":1694724012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201907190-00059"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":22,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016508","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}